Axsome Therapeutics, Inc. SEC filings AXSM

Axsome Therapeutics, Inc. has 672 filings in SEC EDGAR's recent list, going back to Jun 19, 2013. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Apr 24, 2026
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Apr 25, 2025
DEF 14A Proxy statement Apr 26, 2024 Apr 26, 2024
DEF 14A Proxy statement Apr 21, 2023 —
DEF 14A Proxy statement Apr 22, 2022 Apr 22, 2022
DEF 14A Proxy statement Apr 23, 2021 Jun 4, 2021
DEFA14A Additional proxy material May 26, 2020 —
DEFA14A Additional proxy material Apr 21, 2020 —
DEF 14A Proxy statement Apr 21, 2020 Jun 5, 2020
DEF 14A Proxy statement Apr 26, 2019 Jun 7, 2019
DEF 14A Proxy statement Apr 30, 2018 Jun 1, 2018
DEF 14A Proxy statement Apr 28, 2017 Jun 2, 2017
DEF 14A Proxy statement Apr 27, 2016 Jun 10, 2016

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AXSM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Large accelerated filer
SEC CIK
1579428

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.